Maximizing Impact in Baltimore biotech
Blackbird BioVentures invests in early stage biotechnology companies with a focus on building the life sciences ecosystem in Baltimore and the surrounding region.
2024
Y Combinator, Refactor Capital, Khosla Ventures, Knollwood Investment Advisory
2023
Novo Holdings, Third Rock Ventures, Catalio Capital Management, American Cancer Society
2024
DFJ Growth, Eli Lilly, Point72, Brown Advisory, Point Field Partners, Initiate Ventures, Open Field Capital, PTX Capital
2024
General Catalyst, Parker Institute, Alexandria Venture Investments, Catalio Capital Management, Mubadala Capital
2023
OrbiMed, Novo Holdings, F-Prime Capital, Sofinnova Investments, Catalio Capital Management
